In October 2014, pulmonologist Bruce Trapnell, MD, MS, and his collaborators published a groundbreaking report in the journal Nature, demonstrating that transplanting normal or gene-corrected macrophages into the lungs of mice with hereditary pulmonary alveolar proteinosis (PAP) was safe and well-tolerated.